. Author manuscript; available in PMC: 2019 Dec 1.

Published in final edited form as: Lancet Respir Med. 2018 Nov 12;6(12):915–924. doi: 10.1016/S2213-2600(18)30411-9

Table IV.

Deaths at 30 Day and 90 Day

	LR (n=357)	SLR (n=340)	Difference (95% CI)^*	Total (n=697)
30-day mortality	4 (1.1%) - ARDS (2) - Ischemic bowel (1) - Probable PE (1)	2 (0.6%) - ARDS (1 on segment) - Heart failure (1 on wedge)	0.5% (1.1, 2.3)	6 (0.9%)
90-day mortality	6 (1.7%) - ARDS (2) - Bradycardia (1) - Pneumonia (1) - Probable PE(1) - Ischemic bowel (1)	4 (1.2%) - ARDS (1 on segment) - Heart failure (1 on wedge) - Multi organ failure (1 on wedge) - Lung disease (1 on segment)	0.5% (1.5, 2.6)	10 (1.4%)

Miettinen-Nurminen method